Alfa Wassermann and APR business partnership grows stronger: Dicloreumdol®makes it to the Italian market

14 December 2016

Helsinn Group and MEI Pharma Report Prolongation of Survival Results from Phase 2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia

6 December 2016

Helsinn Integrative Care Announces 510(K) FDA Clearance for Medical Device Xonrid® Ge

1 December 2016

APR and Angelini strengthen their partnership in wound care with the launch of Nexodyn® AOS Wound Care Solution in the USA

24 November 2016

BORSE DI STUDIO HELSINN ADVANCED SYNTHESIS 2016/2017 PER 11 STUDENTI DEL CANTON TICINO PER UN VALORE COMPLESSIVO DI 55.000.- CHF

21 November 2016

New scientific data publication on Nexodyn® presented by Key Opinion Leaders

17 November 2016

Switzerland’s hidden pharmaceutical hub

4 November 2016

24.11.2016 – Start-ups, Life Science and Business in Ticino

3 November 2016

Swissmedic approves ALOXI® for use in the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Children in Switzerland

27 October 2016

Antibody Drug Conjugates : Cerbios joins CMC Biologics and IDT Biologika in their Strategic Collaboration offering a fully integrated service to his partners

14 October 2016